251 related articles for article (PubMed ID: 32975060)
1. Association between Atrial Fibrillation and Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.
Kang MK; Park JG; Kim MC
Yonsei Med J; 2020 Oct; 61(10):860-867. PubMed ID: 32975060
[TBL] [Abstract][Full Text] [Related]
2. Association of low skeletal muscle mass with advanced liver fibrosis in patients with non-alcoholic fatty liver disease.
Kang MK; Park JG; Lee HJ; Kim MC
J Gastroenterol Hepatol; 2019 Sep; 34(9):1633-1640. PubMed ID: 30667551
[TBL] [Abstract][Full Text] [Related]
3. Clinical Implications of Cardiac Symptoms and Electrocardiographic Abnormalities for Advanced Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.
Kang MK; Kim MC
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837575
[No Abstract] [Full Text] [Related]
4. The association of non-alcoholic fatty liver disease and atrial fibrillation: a review.
Käräjämäki AJ; Hukkanen J; Ukkola O
Ann Med; 2018 Aug; 50(5):371-380. PubMed ID: 29929399
[TBL] [Abstract][Full Text] [Related]
5. The risk of atrial fibrillation in patients with non-alcoholic fatty liver disease and a high hepatic fibrosis index.
Park HE; Lee H; Choi SY; Kim HS; Chung GE
Sci Rep; 2020 Mar; 10(1):5023. PubMed ID: 32193478
[TBL] [Abstract][Full Text] [Related]
6. Impact of advanced liver fibrosis on atrial fibrillation recurrence after ablation in non-alcoholic fatty liver disease patients.
Wang Z; Wang Y; Luo F; Zhai Y; Li J; Chen Y; Li Q; Zhu L; Jiao S; Liu P; Zhou Y; Chen Y; Dong J; Sun Y
Front Cardiovasc Med; 2022; 9():960259. PubMed ID: 36277780
[TBL] [Abstract][Full Text] [Related]
7. Liver fibrosis scores and atrial fibrillation incidence in heart failure with preserved ejection fraction.
Liu X; Chen W; Shao W; Jiang Y; Cao Z; He W; Wu M; Chen Z; Ma J; Chen Y; Yu P; Zhang Y; Wang J
ESC Heart Fail; 2022 Dec; 9(6):3985-3994. PubMed ID: 35996808
[TBL] [Abstract][Full Text] [Related]
8. Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study).
Käräjämäki AJ; Pätsi OP; Savolainen M; Kesäniemi YA; Huikuri H; Ukkola O
PLoS One; 2015; 10(11):e0142937. PubMed ID: 26571029
[TBL] [Abstract][Full Text] [Related]
9. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis.
Xiao G; Zhu S; Xiao X; Yan L; Yang J; Wu G
Hepatology; 2017 Nov; 66(5):1486-1501. PubMed ID: 28586172
[TBL] [Abstract][Full Text] [Related]
10. High liver fibrosis scores in metabolic dysfunction-associated fatty liver disease patients are associated with adverse atrial remodeling and atrial fibrillation recurrence following catheter ablation.
Decoin R; Butruille L; Defrancq T; Robert J; Destrait N; Coisne A; Aghezzaf S; Woitrain E; Gouda Z; Schino S; Klein C; Maboudou P; Brigadeau F; Klug D; Vincentelli A; Dombrowicz D; Staels B; Montaigne D; Ninni S
Front Endocrinol (Lausanne); 2022; 13():957245. PubMed ID: 36120456
[TBL] [Abstract][Full Text] [Related]
11. High NAFLD fibrosis score in non-alcoholic fatty liver disease as a predictor of carotid plaque development: a retrospective cohort study based on regular health check-up data in China.
Yu X; Chen C; Guo Y; Tong Y; Zhao Y; Wu L; Sun X; Wu X; Song Z
Ann Med; 2021 Dec; 53(1):1621-1631. PubMed ID: 34498502
[TBL] [Abstract][Full Text] [Related]
12. Metabolically healthy versus unhealthy obesity and risk of fibrosis progression in non-alcoholic fatty liver disease.
Kim Y; Chang Y; Cho YK; Ahn J; Shin H; Ryu S
Liver Int; 2019 Oct; 39(10):1884-1894. PubMed ID: 31226232
[TBL] [Abstract][Full Text] [Related]
13. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
[TBL] [Abstract][Full Text] [Related]
14. Association between non-alcoholic fatty liver disease and risk of new-onset atrial fibrillation in healthy adults.
Roh JH; Lee JH; Lee H; Yoon YH; Kim M; Kim YG; Park GM; Park JH; Seong IW
Liver Int; 2020 Feb; 40(2):338-346. PubMed ID: 31479572
[TBL] [Abstract][Full Text] [Related]
15. The Association of leptin with severity of non-alcoholic fatty liver disease: A population-based study.
Rotundo L; Persaud A; Feurdean M; Ahlawat S; Kim HS
Clin Mol Hepatol; 2018 Dec; 24(4):392-401. PubMed ID: 30068065
[TBL] [Abstract][Full Text] [Related]
16. Association between liver fibrosis and coronary heart disease risk in patients with nonalcoholic fatty liver disease.
Dogan S; Celikbilek M; Yilmaz YK; Sarikaya S; Zararsiz G; Serin HI; Borekci E; Akyol L; Pirti I; Davarci SE
Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):298-304. PubMed ID: 25629574
[TBL] [Abstract][Full Text] [Related]
17. Non-invasive fibrosis scoring systems can predict future metabolic complications and overall mortality in non-alcoholic fatty liver disease (NAFLD).
Önnerhag K; Hartman H; Nilsson PM; Lindgren S
Scand J Gastroenterol; 2019 Mar; 54(3):328-334. PubMed ID: 30907181
[No Abstract] [Full Text] [Related]
18. Interatrial septal fat thickness and left atrial stiffness are mechanistic links between nonalcoholic fatty liver disease and incident atrial fibrillation.
Mahfouz RA; Gouda M; Galal I; Ghareb MS
Echocardiography; 2019 Feb; 36(2):249-256. PubMed ID: 30548700
[TBL] [Abstract][Full Text] [Related]
19. Hepatic artery resistive index (HARI) and non-alcoholic fatty liver disease (NAFLD) fibrosis score in NAFLD patients: cut-off suggestive of non-alcoholic steatohepatitis (NASH) evolution.
Tana C; Tana M; Rossi S; Silingardi M; Schiavone C
J Ultrasound; 2016 Sep; 19(3):183-9. PubMed ID: 27635163
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver in USA.
Wijarnpreecha K; Thongprayoon C; Scribani M; Ungprasert P; Cheungpasitporn W
Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):404-410. PubMed ID: 29215435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
